Katharina Kopp

Katharina Kopp studied Pharmaceutical Sciences (B.Sc. and M.Sc.) at the Ludwig-Maximilians Universität (LMU) in Munich, Germany. She has a strong background in Pharmaceutical Technology as she was part of the working group of Prof. Dr. Gerhard Winter at the department of Pharmaceutical Technology for more than two years.

Currently, she is pursuing her PhD as part of the COLOTAN consortium at Eurofins CDMO (Ghent, Belgium) under the supervision of Dr. Jody Voorspoels and Prof. Dr. Guy Van den Mooter (KU Leuven). Her aim is to develop a formulation platform for the targeted delivery of biologics (peptides, antibodies, proteins and nucleic acids) to the colon.